The pharma company received a Warning Letter from the USFDA as a result of the September 2014 inspection, for its facility located at Halol, Gujarat in India.
Subscribe To Our Free Newsletter |
The pharma company received a Warning Letter from the USFDA as a result of the September 2014 inspection, for its facility located at Halol, Gujarat in India.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!